Table 3A.
Appropriate indications.
| N (%) | TYPE, SCORE | |
|---|---|---|
| (1) Symptoms or conditions potentially related to suspected cardiac etiology including but not limited to chest pain, shortness of breath, palpitations, TIA, stroke, or peripheral embolic event. | 270 (53.89%) | A9 |
| (67) Initial evaluation of suspected hypertensive heart disease. | 46 (9.18%) | A8 |
| (24) Initial evaluation of ventricular function following ACS. | 9 (1.79%) | A9 |
| (5) Sustained or non-sustained atrial fibrillation, SVT, or VT. | 8 (1.59%) | A9 |
| (70) Initial evaluation of known or suspected HF (systolic or diastolic) based on symptoms, signs, or abnormal test results. | 6 (1.19%) | A9 |
| (34) Initial evaluation when there is a reasonable suspicion of valvular or structural heart disease. | 6 (1.19%) | A9 |
| (7) Clinical symptoms or signs consistent with a cardiac diagnosis known to cause lightheadedness/pre-syncope/syncope (including but not limited to aortic stenosis, hypertrophic cardiomyopathy, or HF). | 5 (0.99%) | A9 |
| (9) Syncope when there are no other symptoms or signs of cardiovascular disease. | 4 (0.79%) | A7 |
| (59) Suspected pericardial conditions | 3 (0.59%) | A9 |
| (76) Initial evaluation or re-evaluation after revascularization and/or optimal medical therapy to determine candidacy for device therapy and/or to determine optimal choice of device. | 3 (0.59%) | A9 |
| (22) Evaluation of a patient without chest pain but with other features of an ischemic equivalent or laboratory markers indicative of ongoing MI. | 2 (0.39%) | A8 |
| (29) Known acute pulmonary embolism to guide therapy (eg, thrombectomy and thrombolytics). | 2 (0.39%) | A8 |
| (52) Initial evaluation of suspected infective endocarditis with positive blood cultures or a new murmur. | 2 (0.39%) | A9 |
| (73) Re-evaluation of known HF (systolic or diastolic) to guide therapy. | 2 (0.39%) | A9 |
| (17) Routine surveillance (<1 y) of known pulmonary hypertension without change in clinical status or cardiac exam. | 1 (0.19%) | A7 |
| (18) Re-evaluation of known pulmonary hypertension if change in clinical status or cardiac exam or to guide therapy. | 1 (0.19%) | A9 |
| (47) Initial postoperative evaluation of prosthetic valve for establishment of baseline. | 1 (0.19%) | A9 |
| (58) Suspected cardiovascular source of embolus. | 1 (0.19%) | A9 |
| (64) Re-evaluation of known ascending aortic dilation or history of aortic dissection to establish a baseline rate of expansion or when the rate of expansion is excessive. | 1 (0.19%) | A9 |
| (65) Re-evaluation of known ascending aortic dilation or history of aortic dissection with a change in clinical status or cardiac exam or when findings may alter management or therapy. | 1 (0.19%) | A9 |
Note: Results and prevalence of Appropriateness along with their scores according to AUC 2011.
Abbreviations: A, Appropriate; I, Inappropriate; U, Uncertain; N, number; %, percentage.